Other
Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute
Total Trials
3
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed trials have results
Key Signals
1 recruiting1 with results
Enrollment Performance
Analytics
Phase 1
1(50.0%)
N/A
1(50.0%)
2Total
Phase 1(1)
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT04874948Phase 1Completed
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
Role: collaborator
NCT06397248Recruiting
DeVEnIR: Defining Vulvovaginal Candidiasis - Elements of Infection and Remedy
Role: collaborator
NCT03995056Not ApplicableCompleted
Exercise Study in Subjects With NAFLD
Role: collaborator
All 3 trials loaded